Generic Drug

Type: Keyphrase
Name: Generic Drug
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Committee Presses FDA for Documents On Trial Lawyers' Role in Proposed Changes to Generic Drug Labeling

WASHINGTON, DC - House Energy and Commerce Committee members today sent a letter to Food and Drug Administration Commissioner Margaret Hamburg, M.D. expressing their concerns regarding the administration's proposed changes to generic drug labeling. The ... [Published Pharmacy Choice - 12 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Suppliers counteract generic margin compression with targeted mergers, acquisitions

By adding complementary specialty medication offerings to their generic drug businesses, manufacturers are adding instant value and counteracting the margin compression that is occurring as a result of high generic drug utilization.Bloomberg estimates ... [Published Drug Store News - 23 hours ago]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Nothing Generic About Mylan

(ABT) , make them less appealing as well. However, this is certainly not true of generic drug makers. Indeed, spurred by the lower cost of generic medications and the plethora of blockbuster branded ... ... [Published Big News Network - Apr 22 2014]
Entities: Generic Drug
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

IGI Laboratories To Hold Conference Call For 1st Quarter 2014 Results

BUENA, N.J., April 22, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Tuesday, April 29, ... [Published PR Newswire: Health - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Lupin recalls 9,000 bottles of antibiotic drug

Lupin Pharmaceuticals Inc., a subsidiary of Indian drug maker Lupin Ltd., has initiated a recall of almost 10,000 bottles of an antibiotic product, the U.S. Food and Drug Administration (FDA) has announced.The recall is voluntary and was initiated on ... [Published Processing Magazine - Apr 22 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Impax Laboratories picks Frederick Wilkinson as CEO

Generic drug maker Impax Laboratories Inc. chose Frederick Wilkinson as its next CEO.Wilkinson, a research and development executive at Actavis plc, starts work April 29. He takes over from Larry Hsu, who is retiring as CEO of Hayward-based Impax (NASDAQ: ... [Published Business First of Buffalo - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 2 reports

'Reddy' For An Emerging Healthcare Play In Generic Pharmaceuticals?

By Amit H. Shah :The healthcare industry has a storyline with mass appeal that is fit for a soap opera. As a soap opera, the narrative is open-ended and there are many concurrent sub-plots that eventually intermix. The business model for companies developing ... [Published BioPortfolio - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Employers' association says HZZO destroying domestic drug industry

The Croatian Employers' Association (HUP) has accused the Health Insurance Fund (HZZO) of undermining the domestic pharmaceutical industry, which the Economy Ministry considers one of the engines of the national economy, by constantly lowering the prices ... [Published Dalje.com - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

EXCLUSIVE: Liberals to release 'Pocketbook' progress report

The minority Liberals are expected to announce some saving on your energy bills later in the week but before they do that, they are reminding voters other ways they've reduced the strain on your wallet.Bell Media radio has learned the progress report ... [Published 97.7 HTZ FM - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Natco Pharma jumps as SC rejects Teva's appeal seeking prevention of a generic drug launch

Natco Pharma surged 7.45% to Rs 769 at 11:48 IST on BSE after the company said that Supreme Court Chief Justice Roberts has denied Teva's application for an injunction seeking to prevent launch of a generic version of Copaxone. The announcement was made ... [Published India Infoline - Apr 21 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Sun Pharma continues to outglow its peers

Performance is built into the DNA of Sun Pharma. The company has consistently outperformed peers and the market and 2013-14 was no exception. Last year, the company added Rs 35,000 crore, or 44 per cent, to the wealth of its shareholders.In the first ... [Published Business Standard India - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Government Causes Generic Drug Shortage, Critics Say

A proposed Food and Drug Administration rule on product labeling will exacerbate shortages of generic drugs already resulting from regulations on Medicare reimbursement rates and other factors, critics charge. ... [Published NewsMax.com - Apr 17 2014]

Quotes

"Abilify doesn't raise the bloodblood sugar as much as some other drugs, so there are a number of patients, with other conditions, who would need it" he said
...Further, as the letter states, "it is not at allall clear why plaintiffs lawyers would have any role in the development and review of the proposed rule."
The California-based company said that the poisonpoison pill defence "is not intended to prevent an acquisition of the company on terms that the board considers favourable to, and in the best interests of, all stockholders, rather, it aims to provide the board with adequate time to fully assess any proposal."
"It gives us much more of a durable cash flow profile in the future" Witty said in an interview with Bloomberg Television

More Content

All (901) | News (783) | Reports (0) | Blogs (104) | Audio/Video (1) | Fact Sheets (3) | Press Releases (5)
sort by: Date | Relevance
State senator questions Medicaid's use of brand... [Published Cleburne News - 20 mins ago]
Omnicare's CEO Discusses Q1 2014 Results - Earn... [Published Seeking Alpha - 7 hours ago]
Bergman: ‘Armchair criticism’ of Medicare [Published Milford Daily News - 10 hours ago]
Committee Presses FDA for Documents On Trial La... [Published Pharmacy Choice - 12 hours ago]
AxoGen (AXGN) in Focus: Stock Moves 5.7% Higher... [Published Nasdaq - 12 hours ago]
Quartz Daily Brief—Americas edition—Apple’s ear... [Published Quartz - 16 hours ago]
Valeant tables hostile $45.7 bn bid for Botox m... [Published domain-b - 18 hours ago]
Glaxo deals shift company's focus to vaccines, ... [Published Denver Post - 20 hours ago]
AxoGen (AXGN) in Focus: Stock Moves 5.7% Higher [Published Yahoo! Finance - 20 hours ago]
Suppliers counteract generic margin compression... [Published Drug Store News - 23 hours ago]
Dobutamine in Paediatric Population: A Systemat... [Published PLoS medicine - Apr 22 2014]
Physician Behavior Impact When Revenue Shifted ... [Published American Journal of Managed Care - Apr 22 2014]
This is the 1 Thing AstraZeneca Should Do to Im... [Published Motley Fool - Apr 22 2014]
How Prescriptions Get Switched Legally [Published Sermo.com - Apr 22 2014]
Pharma 'blockbuster' rumours swirl after Glaxo ... [Published Guardian.co.uk - Apr 22 2014]
Allergan takeover rewrites activist investor rules [Published MSN Money - Apr 22 2014]
Jefferies Initiates Coverage on Specialty Pharm... [Published 24/7 Wall St - Apr 22 2014]
Obama Travels to Asia But Future of Trade Pact ... [Published Yale Global Online - Apr 22 2014]
Nothing Generic About Mylan [Published Big News Network - Apr 22 2014]
IGI Laboratories To Hold Conference Call For 1s... [Published TickerTech.com - Apr 22 2014]
IGI Laboratories To Hold Conference Call For 1s... [Published PR Newswire: Health - Apr 22 2014]
India not to budge under US pressure on IPR issues [Published PharmaBiz - Apr 22 2014]
Luthra, Amarchand, Crawford, Shearman, Davis Po... [Published Bar & Bench - Apr 22 2014]
Africa Pharmaceutical Summit Coming To Accra [Published Modern Ghana - Apr 22 2014]
The pharma industry’s blockbuster $29 billion, ... [Published Quartz - Apr 22 2014]
Glenmark Shares hit on loss of Tarka patent appeal [Published NDTV Profit - Apr 22 2014]
Progress Report on Helping People with their Ev... [Published BusinessWeek - Apr 22 2014]
Sidley Austin LLP global pricing newsletter - v... [Published Lexology - Apr 22 2014]
Lupin recalls 9,000 bottles of antibiotic drug [Published Processing Magazine - Apr 22 2014]
US Court Clears Way for Natco's Copaxone Launch [Published New Indian Express - Apr 22 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
IGI Laboratories To Hold Conference Call For 1s... [Published PR Newswire: Health - Apr 22 2014]
BUENA, N.J., April 22, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Tuesday, April 29, ...
Court won’t block Teva rivals [Published SCOTUSblog - Apr 18 2014]
Chief Justice John G. Roberts, Jr., refused on Friday afternoon to delay generic drug manufacturers from offering, as early as next month, competing and lower-priced versions of a widely used drug for treating multiple sclerosis.  In a one-page ruling, ...
Generic Drugmakers Fight Teva’s Bid to Stall Co... [Published Wall St. Cheat Sheet - Apr 17 2014]
Generic drugmakers asked the U.S. Supreme Court to allow them to introduce generic versions of   Teva Pharmaceutical Industries Ltd.’s ( NYSE:TEVA ) Copaxone multiple-sclerosis drug onto the market next month, according to Reuters and Bloomberg ...
The Switchboard: Al Franken seeks Netflix’s aid... [Published Faster Forward - Apr 17 2014]
Sen. Al Franken, D-Minn., confers with an aide as the Senate Judiciary subcommittee on Antitrust, Competition Policy and Consumer Rights holds a hearing on "pay-for-delay" deals between pharmaceutical companies and their generic drug competitors, which ...
The Switchboard: Al Franken seeks Netflix’s aid... [Published Post Tech - Apr 17 2014]
Sen. Al Franken, D-Minn., confers with an aide as the Senate Judiciary subcommittee on Antitrust, Competition Policy and Consumer Rights holds a hearing on "pay-for-delay" deals between pharmaceutical companies and their generic drug competitors, which ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
CVS finds right prescription for profits [Published Reuters Video: Business - Feb 11 2014]
1

Press Releases

sort by: Date | Relevance
NEW ECONOMIC ANALYSIS SHOWS THAT FDA PROPOSED G... [Published Financial Services - Feb 05 2014]
ANI Pharmaceuticals Acquires 31 Generic Drug Pr... [Published Financial Services - Dec 26 2013]
CVS Caremark And Cardinal Health Announce Creat... [Published Financial Services - Dec 10 2013]
CVS Caremark And Cardinal Health Announce Creat... [Published Financial Services - Dec 10 2013]
Genovate and ScinoPharm Co-Develop Hepatitis B ... [Published Financial Services - Nov 11 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.